4.4 Article

Vitamin D3 actions on astrocyte cells: A target for therapeutic strategy in Parkinson's disease?

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease

Erlania Alves de Siqueira et al.

Summary: The neuroprotective activity of 1 alpha,25-dihydroxy vitamin D3 (VD3) on the cytotoxicity induced by rotenone (ROT) in PC12 cells was evaluated. VD3 was shown to improve cell viability, decrease oxidative stress, and improve mitochondrial function in ROT-exposed cells.

NEUROCHEMICAL RESEARCH (2023)

Review Clinical Neurology

Evidence of Inflammation in Parkinson's Disease and Its Contribution to Synucleinopathy

Thuy Thi Lai et al.

Summary: The accumulation of alpha-synuclein in neurons and activated inflammatory responses are key factors in the pathogenesis of Parkinson's disease. Understanding the interaction between inflammation and synucleinopathy can lead to the development of promising disease-modifying therapies. Research in human, animal, and laboratory studies is crucial in exploring new therapeutic targets associated with this relationship.

JOURNAL OF MOVEMENT DISORDERS (2022)

Article Neurosciences

Astrocytes expressing Vitamin D-activating enzyme identify Parkinson's disease

Samanta Mazzetti et al.

Summary: This study found a specific subpopulation of astrocytes in the brains of Parkinson's disease (PD) patients, which can protect neurons by sequestering alpha-Synuclein oligomers and are associated with Lewy body negative neurons. These findings suggest the potential neuroprotective role of the vitamin D pathway in neurodegenerative diseases.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

Review Clinical Neurology

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models

Angeliki Spathopoulou et al.

Summary: Parkinson's disease is a progressive neurological disorder with no cure. Understanding the underlying mechanisms and finding new treatments are crucial. Induced pluripotent stem cell-derived neural models have the potential to reveal the pathophysiology of Parkinson's disease and facilitate the development of new therapies.

FRONTIERS IN NEUROLOGY (2022)

Review Cell Biology

Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity

Wen Gao et al.

Summary: Nrf2 and NF-kappa B are important regulators of oxidative stress and inflammation in the body, and there is crosstalk between them. Drug-induced organ toxicity has become a focus of research in clinical practice, and it is urgent to find protective drugs to alleviate this injury. Evidence suggests that modulating both Nrf2 and NF-kappa B pathways can alleviate drug-induced organ toxicity. Therefore, exploring the crosstalk mechanism between Nrf2 and NF-kappa B is of great importance.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Neurosciences

Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice

Savannah M. Rocha et al.

Summary: This study establishes a reproducible murine model of rotenone-induced Parkinson's disease and explores the effects of rotenone exposure on neuroinflammation, protein aggregation, and loss of dopaminergic neurons. The results indicate that rotenone exposure leads to progressive accumulation and regional spread of p129 aggregates, which precede the maximal loss of dopaminergic neurons. The activation of glial cells and aggregation of p129 appear to be driving factors in neurodegeneration following rotenone-induced neurotoxic stress.

NEUROBIOLOGY OF DISEASE (2022)

Article Nutrition & Dietetics

Vitamin D and Parkinson's Disease

Antonia Pignolo et al.

Summary: Vitamin D plays a crucial role in bone metabolism, calcium and phosphorous homeostasis, as well as brain development and neuroprotection. Patients with Parkinson's disease often have a high frequency of vitamin D deficiency, which may be related to disease severity and progression. However, the evidence regarding the use of vitamin D supplementation to reduce symptoms and disability in patients with Parkinson's disease is limited. Further clinical studies are needed to confirm the potential benefits and risks of vitamin D supplementation in this population.

NUTRIENTS (2022)

Review Immunology

Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification

Alexander Grotemeyer et al.

Summary: This article discusses the pathophysiology and neurodegeneration of Parkinson's disease, focusing on interconnected pathways related to the immune response. It also provides an overview of clinical trials targeting neuroinflammation in Parkinson's disease.

FRONTIERS IN IMMUNOLOGY (2022)

Review Chemistry, Medicinal

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies

Sibel Suzen et al.

Summary: Neurodegenerative diseases are characterized by high levels of oxidative stress biomarkers and low levels of antioxidant protection; Dysregulation of the oxidant/antioxidant balance is a major factor in the pathogenesis of these diseases; Nrf2 plays a protective and defending role against neurodegenerative conditions.

PHARMACEUTICALS (2022)

Review Geriatrics & Gerontology

Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review

Mobina Fathi et al.

Summary: Parkinson's disease is characterized by neuroinflammation, and several protein factors and pathways are implicated in the development of PD and other neurodegenerative diseases.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Vitamin D3 Inhibits Phagocytic Activity of Rat Brain Astrocytes in Primary Culture

T. Sokolova et al.

Summary: Vitamin D3 can inhibit the phagocytic activity of brain astrocytes, which is important in developing new treatment strategies for neurodegenerative diseases associated with the accumulation of apoptotic substrates.

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY (2022)

Review Immunology

Inflammation and immune dysfunction in Parkinson disease

Malu Gamez Tansey et al.

Summary: This review explores the role of an ageing immune system, host genetics, and exposure to environmental stressors in promoting the development of Parkinson's disease. It discusses the presence of neuroinflammation and alterations in immune cell populations as well as the potential contributions of viral or bacterial exposure, pesticides, and gut microbiota to disease pathogenesis.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Neurosciences

Nuclear factor-kappa B (NF-κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration

Mahsa Dolatshahi et al.

Summary: NF-κB activation plays a key role in Parkinson's disease, with both beneficial effects on neuronal survival and detrimental effects leading to neuronal loss. By targeting the signaling pathways and mechanisms associated with NF-κB, it is possible to effectively attenuate DA neuron loss and the progression of Parkinson's disease.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Epigenetic Regulation of Neuroinflammation in Parkinson's Disease

Madiha Rasheed et al.

Summary: Neuroinflammation plays a significant role in the initiation and progression of Parkinson's disease, activating the neuronal immune system and triggering a vicious cycle of inflammation-induced dopaminergic neuron damage. Epigenetic mechanisms are at the forefront of regulating neuroinflammatory factors, offering potential for breaking this cycle. These mechanisms do not work independently but cooperatively, impacting various neuroinflammatory pathways and potentially influencing PD development.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery

Anna Picca et al.

Summary: Parkinson's Disease is a common neurodegenerative disease among older adults, characterized by dopaminergic neuron loss and abnormal accumulation of alpha-synuclein. The development of PD involves various factors such as genetic mutations, post-translational modifications, and mitochondrial dysfunction. The overproduction of reactive oxygen species activates alpha-synuclein aggregation, leading to neurodegeneration.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Astrocytes, a Promising Opportunity to Control the Progress of Parkinson's Disease

Alberto Sanchez et al.

Summary: Currently, there is no efficient treatment to prevent the evolution of Parkinson's disease, which is generated by the concurrent activity of multiple factors, posing a serious obstacle for the development of etio-pathogenic treatments. Astrocytes may play a key role in controlling the main causes of PD and promoting their neuroprotection activity to prevent the onset and progression of this basal ganglia disorder.

BIOMEDICINES (2021)

Review Physiology

Vitamin D Promotes Skeletal Muscle Regeneration and Mitochondrial Health

Christine M. Latham et al.

Summary: Vitamin D plays a crucial role in muscle regeneration and maintenance, protecting muscle structure and mitochondrial function, and promoting the activity of muscle stem cells.

FRONTIERS IN PHYSIOLOGY (2021)

Review Neurosciences

Parkinson's Disease Genetics and Pathophysiology

Gabriel E. Vazquez-Velez et al.

Summary: Parkinson's disease is a common neurodegenerative disorder characterized by degeneration of the substantia nigra pars compacta and accumulation of alpha-synuclein in Lewy bodies. Genetic factors play an important role in PD pathophysiology, with dysfunction of endosomal, lysosomal, and mitochondrial pathways being associated with the disease. This knowledge could be utilized for developing disease-modifying therapeutics.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 44, 2021 (2021)

Article Cell Biology

Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB

Tsui-Wen Chou et al.

Summary: This study reveals that preformed fibrils of alpha-synuclein induce pathogenic activation of human midbrain astrocytes, involving inflammatory responses, downregulation of phagocytic function, and conferral of neurotoxic activity. These effects are dependent on necroptotic kinases RIPK1 and RIPK3, but do not involve MLKL or necroptosis. The activation of astrocytes occurs through RIPK-dependent activation of NF-kappa B signaling, highlighting new roles for RIP kinase signaling in regulating glial cell biology and neuroinflammation, with implications for Parkinsonian neurodegeneration.

CELL DEATH & DISEASE (2021)

Article Cell Biology

Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models

Qing Guo et al.

Summary: Activation of Nrf2 in astrocytes plays a crucial neuroprotective role in PD models through the antioxidant signaling pathway and autophagy enhancement. This study provides new insights into the mechanisms of Nrf2-antioxidant-autophagy signaling and potential targets for PD interventions.

CELLS (2021)

Article Geriatrics & Gerontology

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology

David K. Simon et al.

CLINICS IN GERIATRIC MEDICINE (2020)

Article Clinical Neurology

Systemic activation of Nrf2 pathway in Parkinson's disease

Sara Petrillo et al.

MOVEMENT DISORDERS (2020)

Review Biochemistry & Molecular Biology

Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular

Sandra Buratta et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Geriatrics & Gerontology

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease

Arianna Bellucci et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Review Clinical Neurology

A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms

Michelle E. Fullard et al.

FRONTIERS IN NEUROLOGY (2020)

Article Pharmacology & Pharmacy

Vitamin D (VD3) antioxidative and anti-inflammatory activities: Peripheral and central effects

Luzia Kalyne Almeida Moreira Leal et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

NRF2, a Transcription Factor for Stress Response and Beyond

Feng He et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Metabolic alterations in Parkinson's disease astrocytes

Tuuli-Maria Sonninen et al.

SCIENTIFIC REPORTS (2020)

Review Cell Biology

Neuron-Astrocyte Interactions in Parkinson's Disease

Ikuko Miyazaki et al.

CELLS (2020)

Review Neurosciences

Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System

Pierre Antoine Faye et al.

FRONTIERS IN NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms

Minna Oksanen et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Review Immunology

Cellular Specificity of NF-κB Function in the Nervous System

Erica C. Dresselhaus et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Neurosciences

Rotenone: from modelling to implication in Parkinson's disease

Khaled Radad et al.

FOLIA NEUROPATHOLOGICA (2019)

Article Neurosciences

Overexpression of -synuclein in an astrocyte cell line promotes autophagy inhibition and apoptosis

Adolfo Garcia Erustes et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2018)

Review Cell Biology

Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs

Simona Paladino et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Biochemistry & Molecular Biology

The role of Nrf2 signaling in counteracting neurodegenerative diseases

Albena T. Dinkova-Kostova et al.

FEBS JOURNAL (2018)

Review Immunology

Inflammation in CNS neurodegenerative diseases

Jodie Stephenson et al.

IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact

Rita Moretti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Neurosciences

The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis

Heather D. E. Booth et al.

TRENDS IN NEUROSCIENCES (2017)

Article Biochemistry & Molecular Biology

Dissecting molecular cross-talk between Nrf2 and NF-kappa B response pathways

Joanna D. Wardyn et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2015)

Review Neurosciences

NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review

Ruey-Horng Shih et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)

Article Clinical Neurology

NF-κB in innate neuroprotection and age-related neurodegenerative diseases

Annamaria Lanzillotta et al.

FRONTIERS IN NEUROLOGY (2015)

Article Cell Biology

Astrogliosis

Michael V. Sofroniew

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)

Article Biochemical Research Methods

Analysis of GSH and GSSG after derivatization with N-ethylmaleimide

Daniela Giustarini et al.

NATURE PROTOCOLS (2013)

Article Biochemistry & Molecular Biology

Rotenone Could Activate Microglia Through NFκB Associated Pathway

Yu-he Yuan et al.

NEUROCHEMICAL RESEARCH (2013)

Review Geriatrics & Gerontology

Copper metabolism of astrocytes

Ralf Dringen et al.

FRONTIERS IN AGING NEUROSCIENCE (2013)

Review Biochemistry & Molecular Biology

Glutathione dysregulation and the etiology and progression of human diseases

Nazzareno Ballatori et al.

BIOLOGICAL CHEMISTRY (2009)

Review Pharmacology & Pharmacy

Targeting apoptosis as an approach for gastrointestinal cancer therapy

Liang Qiao et al.

DRUG RESISTANCE UPDATES (2009)

Article Medicine, Research & Experimental

NF-κB in neuronal plasticity and neurodegenerative disorders

MP Mattson et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)